UBS AM’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$682 Sell
222
-161,902
-100% -$701K ﹤0.01% 3708
2025
Q4
$577K Buy
162,124
+71
+0% +$435 ﹤0.01% 2297
2025
Q3
$1.44M Sell
162,053
-65,688
-29% -$666K ﹤0.01% 1877
2025
Q2
$2.1M Buy
227,741
+129,107
+131% +$1.1M ﹤0.01% 2115
2025
Q1
$846K Buy
+98,634
New +$931K ﹤0.01% 2373
2024
Q2
Sell
-96,924
Closed -$493K 2807
2024
Q1
$493K Hold
96,924
﹤0.01% 2289
2023
Q4
$902K Hold
96,924
﹤0.01% 2087
2023
Q3
$635K Hold
96,924
﹤0.01% 2186
2023
Q2
$831K Hold
96,924
﹤0.01% 2087
2023
Q1
$831K Buy
+96,924
New +$967K ﹤0.01% 2087
2022
Q4
Sell
-96,244
Closed -$993K 2580
2022
Q3
$993K Hold
96,244
﹤0.01% 1975
2022
Q2
$963K Buy
96,244
+31,859
+49% +$302K ﹤0.01% 1987
2022
Q1
$793K Hold
64,385
﹤0.01% 2260
2021
Q4
$1.12M Sell
64,385
-4,366
-6% -$83K ﹤0.01% 2154
2021
Q3
$1.23M Buy
68,751
+567
+0.8% +$11.3K ﹤0.01% 2051
2021
Q2
$1.56M Buy
+68,184
New +$1.01M ﹤0.01% 1970

Other funds holding AVXL